News
The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...
The CSO report found that most people aged 25 believed themselves to be in excellent (22.7%) or very good (42%) health at the time of the survey ...
Market volatility has led to compelling dividend opportunities, and Merck and Schlumberger offer great value at low PE ratios ...
The HPV vaccine can prevent cancers, including cervical cancer. It's recommended for girls between the ages nine and 45. Only ...
World Immunization Week 2025 brings global attention to the life-saving impact of vaccines and urges stronger action as ...
In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...
4d
Investor's Business Daily on MSNGardasil Sales Decline — Again. Can Dow Jones Stock Merck Take The Hit?Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...
The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.
Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results